BridgeBio Pharma, Inc. Total Assets

Total Assets of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total Assets growth rates and interactive chart. Total assets are the sum of all current and noncurrent assets and must equal the sum of total liabilities and stockholders' equity combined. In the accounting industry, assets are defined as anything that a business owns, has value, and can be converted to cash.

Highlights and Quick Summary

  • Total Assets for the quarter ending September 30, 2022 was $729 Million (a -15.43% decrease compared to previous quarter)
  • Year-over-year quarterly Total Assets decreased by -28.04%
  • Annual Total Assets for 2021 was $1.01 Billion (a 43.95% increase from previous year)
  • Annual Total Assets for 2020 was $704 Million (a 11.38% increase from previous year)
  • Annual Total Assets for 2019 was $632 Million (a 35.86% increase from previous year)
Visit stockrow.com/BBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total Assets of BridgeBio Pharma, Inc.

Most recent Total Assetsof BBIO including historical data for past 10 years.

Interactive Chart of Total Assets of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. Total Assets for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – $729.0 $862.0 $813.0 –
2021 $1,013.0 $782.0 $1,081.49 $1,093.31 $1,012.79
2020 $703.59 $787.69 $905.23 $989.8 $703.59
2019 $631.68 $640.53 $0.0 $0.0 $631.68
2018 – – $0.0 $0.0 $464.94
2017 $0.0 – – – $0.0

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com